Company: APXT
Filing Date: 2025-10-28
Form Type: 424B4
Source: 0001213900-25-103160
Chunk: 5

Company: Apex Treasury Corp
Filing Date: 2025-10-28
Form: 424B4
Chunk 5
---
 amount of deferred underwriting compensation may not allow us to complete the most desirable business combination or optimize our capital structure, and may substantially dilute your investment in us” on page52, “ Risk Factors — We may issue additional Class A ordinary shares or preference shares to complete our initial business combination or under an employee incentive plan after completion of our initial business combination. We may also issue Class A ordinary shares upon the conversion of the Class B ordinary shares at a ratio greater than one -to -one at the time of our initial business combination as a result of the anti -dilution provisions contained therein. Any such issuances would dilute the interest of our shareholders and likely present other risks” on page66, “ Dilution” on page 104 and “ Proposed Business — Our Sponsor” on page 123 for more information. In addition, our sponsor and the underwriters have committed to purchase an aggregate of 8,000,000 warrants (or 8,900,000 warrants if the underwriters’ over -allotmentoption is exercised in full), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $8,000,000 (or $8,900,000 if the underwriters’ overallotment option is exercised in full), in a private placement that will close simultaneously with the closing of this offering, which we refer to collectively as the “private placement warrants.” Of those 8,000,000 private placement warrants (or 8,900,000 private placement warrants if the underwriters’ overallotment option is exercised in full), our sponsor has agreed to purchase 5,000,000 (or 5,450,000 private placement warrants if the underwriters’ overallotment option is exercised in full) private placement warrants and the underwriters have agreed to purchase 3,000,000 private placement warrants (or 3,450,000 private placement warrants if the underwriters’ overallotment option is exercised in full). Each whole private placement warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described herein. The private placement warrants will become exercisable 30 days after the completion of our initial business combination, as described in this prospectus. The private placement warrants are identical to the public warrants sold in this offering, subject to certain limited exceptions as described in this prospectus. Our public shareholders